Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen)

J Exp Med. 1985 Jun 1;161(6):1513-24. doi: 10.1084/jem.161.6.1513.

Abstract

In previous studies (17-21), monoclonal antibody (mAb) 9.3 has been shown to react with a major population of human T cells, which include T4+ helper/inducer T cells and T8+ cytotoxic T cells. In this investigation, mAb 9.3 was shown to precipitate a disulfide-bonded dimer of a 44 kD polypeptide. Comodulation experiments showed that this molecule is not linked to T3/Ti or T11 antigens. mAb 9.3 was capable of inducing T cell proliferation in the presence of 12-o-tetradecanoyl phorbol-13-acetate (TPA). This effect was monocyte-independent. T cell activation with mAb 9.3 and TPA was associated with increases in interleukin 2(IL-2) receptor expression and IL-2 secretion. mAb 9.3 did not activate T cells, even with the addition of IL-1 or IL-2. Modulation of the T3 complex did not abolish mAb 9.3-induced T cell proliferation in the presence of TPA. These results suggest that the 9.3 antigen may serve as a receptor for an activation pathway restricted to a T cell subset.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Antigens, Surface / immunology*
  • CD3 Complex
  • Humans
  • In Vitro Techniques
  • Interleukin-1 / immunology
  • Interleukin-2 / immunology
  • Lymphocyte Activation*
  • Protein Conformation
  • Receptors, Antigen, T-Cell / immunology
  • Receptors, Immunologic
  • T-Lymphocytes / classification
  • T-Lymphocytes / immunology*
  • Tetradecanoylphorbol Acetate / pharmacology

Substances

  • Antibodies, Monoclonal
  • Antigens, Surface
  • CD3 Complex
  • Interleukin-1
  • Interleukin-2
  • Receptors, Antigen, T-Cell
  • Receptors, Immunologic
  • Tetradecanoylphorbol Acetate